Commercial

(CVE:CA:SSS) (“SCT” or the “Company”) a life sciences development company of stem cell-related therapeutics, today reported its operational and financial results for the 2011 fiscal year, ended December 31. The second half of 2011 was dedicated to …
[Read more]

FREE SUBSCRIPTION

Just fill in your email address, we will send you the latest market update periodically.

Contact Us

Name*

Email*

Tel

Message*

captcha

*require